Page last updated: 2024-11-10

vitamin a acid ethylamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

vitamin A acid ethylamide: ethylamide of all-trans B-retinoic acid; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5288173
CHEMBL ID418471
SCHEMBL ID1446600
MeSH IDM0054571

Synonyms (23)

Synonym
ccris 4283
brn 1999616
retinamide, n-ethyl-, all-trans-
retinoic acid ethyl amide
retinamide, n-ethyl-
ro 8-4968
DB03917
ethyl retinamide
n-ethylretinamide
all-trans-n-ethylretinamide
vitamin a acid ethylamide
1ERB
CHEMBL418471
SCHEMBL1446600
6lm987k76y ,
33631-41-3
unii-6lm987k76y
retinamide,n-ethyl-
all-trans-ethylretinamide
15-(ethylamino)retinal
Q27094778
n-(ethyl)retinamide
DTXSID101316413

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Based on the lethality data, all-trans-retinoic acid was most toxic followed by all-trans-HER greater than all-trans-HPR greater than all-trans-ER."( Subacute toxicity of all-trans- and 13-cis-isomers of N-ethyl retinamide, N-2-hydroxyethyl retinamide, and N-4-hydroxyphenyl retinamide.
Meeks, RG; Sani, BP, 1983
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, RETINOL BINDING PROTEINBos taurus (cattle)Kd0.00800.00800.00800.0080AID977611
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1811Experimentally measured binding affinity data derived from PDB1993The Journal of biological chemistry, Nov-25, Volume: 268, Issue:33
The interaction of N-ethyl retinamide with plasma retinol-binding protein (RBP) and the crystal structure of the retinoid-RBP complex at 1.9-A resolution.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB1993The Journal of biological chemistry, Nov-25, Volume: 268, Issue:33
The interaction of N-ethyl retinamide with plasma retinol-binding protein (RBP) and the crystal structure of the retinoid-RBP complex at 1.9-A resolution.
AID84861Reversal of keratinization in vitamin A deficient hamster trachea culture1988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
N-(Retinoyl)amino acids. Synthesis and chemopreventive activity in vitro.
AID199394Dissociation constant with retinol binding protein was determined2000Bioorganic & medicinal chemistry letters, Sep-18, Volume: 10, Issue:18
HINT predictive analysis of binding between retinol binding protein and hydrophobic ligands.
AID19234Partition coefficient (logP)2000Bioorganic & medicinal chemistry letters, Sep-18, Volume: 10, Issue:18
HINT predictive analysis of binding between retinol binding protein and hydrophobic ligands.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (82.35)18.7374
1990's2 (11.76)18.2507
2000's1 (5.88)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.41 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]